
About the organisation
The Asian Fund for Cancer Research Limited (AFCR) is committed to fund cancer research, especially those cancers prevalent in Asian populations, and promote global collaborations for high impact to save the lives of cancer patients. We believe that research holds the key that may end cancer. That’s why at AFCR, we place the highest priority in advancing cutting-edge cancer research in all important fields that will lead to better preventative methods, advanced diagnostic tools, more effective treatment approaches. We fund projects in a variety of important research fields, such as overcoming cancer’s resistance to chemotherapy, developing new screening tests for early detection, optimizing approaches of personalized medicine, and stopping cancer metastasis, etc. AFCR provides the public with a wide variety of in-depth, user-friendly cancer prevention information and healthy lifestyle suggestions. We help the community understand the latest scientific achievements and their potential significance to improve the prevention, diagnosis and treatment of cancer. Armed with this knowledge, people can better protect themselves against cancer.
Contact
- Address
- Room 2914, Hong Kong Plaza, 188 Connaught Road West, Hong Kong Central, Hong Kong 999077, HK (Open in Google Maps)
- Phone
- 2156 9684
- contact@afcr.org
- Website
- www.AFCR.org/
Social links
Focus Areas
Target beneficiaries
Categories
Sustainable Development Goals
Governance & transparency
Directors
Gary Gee Nung WONG,Cheung Hoi YU,Joseph Perchow CHANG,Franck LE DEU,Yajun XU
- Annual report on website
- No
- Financial audits on website
- No
- Board of directors on website
- No
Organisation structure
Company limited by guarantee under the Companies Ordinance
Other
- Subvented HK Charity
- No
- Effective date (charity status)
- 9 September 2005
Disclaimer
Last updated: Feb 27, 2026
Information provided may be inaccurate or outdated. Details about this organisation are based on publicly available information and should be independently verified. Read full disclaimer.
